Anish K. Vadukoot, Ph.D
Anish K. Vadukoot earned his Doctorate in Chemistry (August 2016) under the guidance of Dr. Edward J. Merino from University of Cincinnati. His work involved design and development of novel chemical scaffolds to effectively and selectively target cancer cells through Reactive Oxygen Species (ROS) induced apoptotic signaling. Dr. Vadukoot next completed a Postdoctoral Fellowship at University of Nebraska Medical Center (UNMC) from August 2016-March 2019, under the supervision of Dr. Corey R. Hopkins. In this role, he was extensively trained in medicinal chemistry, pharmacokinetics (in vitro and in vivo), and drug discovery and development of novel lead scaffolds for various CNS-related disorders (Parkinson’s, GIRK1/2 activators as novel anxiolytics, Chronic Obstructive Pulmonary Disease). He joined Southern Research as Scientist I in March 2019 where his current research involves the design, synthesis and development of novel anti-HIV agents. He also provides medicinal chemistry efforts in the area of antiviral drug discovery for the Antiviral Drug Discovery and Development Center (AD3C), a Center of Excellence for Translation Research (CETR), funded through NIAID, NIH.